| A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice WJ Aston, DE Hope, AK Nowak, BW Robinson, RA Lake, WJ Lesterhuis BMC cancer 17, 1-10, 2017 | 182 | 2017 |
| Transient Treg depletion enhances therapeutic anti‐cancer vaccination SA Fisher, WJ Aston, J Chee, A Khong, AL Cleaver, JN Solin, S Ma, ... Immunity, inflammation and disease 5 (1), 16-28, 2017 | 43 | 2017 |
| Dexamethasone differentially depletes tumour and peripheral blood lymphocytes and can impact the efficacy of chemotherapy/checkpoint blockade combination treatment WJ Aston, DE Hope, AM Cook, L Boon, I Dick, AK Nowak, RA Lake, ... Oncoimmunology 8 (11), e1641390, 2019 | 28 | 2019 |
| Combining chemotherapy and checkpoint blockade in thoracic cancer: how to proceed? WJ Aston, SA Fisher, A Khong, C Mok, AK Nowak, RA Lake, ... Lung Cancer Management 3 (6), 443-457, 2014 | 8 | 2014 |
| CD4+ T cells drive an inflammatory, TNF-α/IFN-rich tumor microenvironment responsive to chemotherapy CM Tilsed, N Principe, J Kidman, WL Chin, MLO Morales, RM Zemek, ... Cell Reports 41 (13), 2022 | 6 | 2022 |
| Comprehensive testing of chemotherapy and immune checkpoint blockade in preclinical cancer models identifies additive combinations N Principe, WJ Aston, DE Hope, CM Tilsed, SA Fisher, L Boon, IM Dick, ... Frontiers in immunology 13, 872295, 2022 | 5 | 2022 |
| Chemo-Immunotherapy: Exploiting the Immunogenic Potential of Chemotherapy in Thoracic Cancer W Aston | | 2019 |
| Targeted depletion of regulatory T cells in solid cancers S Fisher, J Solin, W Aston, A Cleaver, WJ Lesterhuis, A Khong, ... EUROPEAN JOURNAL OF IMMUNOLOGY 46, 231-231, 2016 | | 2016 |
| Cancer chemo immunotherapy-exploiting the immunogenic potential of cytotoxic chemotherapy WJ Aston, C Rinaldi, SA Fisher, AK Nowak, RA Lake, WJ Lesterhuis EUROPEAN JOURNAL OF IMMUNOLOGY 46, 239-239, 2016 | | 2016 |
